Filing Details

Accession Number:
0001209191-21-006787
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-02 16:28:49
Reporting Period:
2021-01-30
Accepted Time:
2021-02-02 16:28:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1515673 Ultragenyx Pharmaceutical Inc. RARE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1326969 L Camille Bedrosian C/O Ultragenyx Pharmaceutical Inc.
60 Leveroni Court
Novato CA 94949
Evp And Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-01-30 2,243 $140.36 33,546 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").
  2. Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.